Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 835

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 835
---
 as [standard] indemnity, exemption, and insurance provisions. Note 23: — SUBESEQUENT Events A. Conditions precedent remaining for the completion of the merger transaction with NLS and the extension of the final deadline for its completion: 1.On February 2, 2025, the Company announced that it continues to work jointly with NLS vis -a-visvarious regulatory bodies (including the U.S. Securities and Exchange Commission (the “SEC”) and the Nasdaq Stock Exchange) in order to obtain all necessary approvals required for the completion of the merger transaction. In addition, NLS is taking steps to convene a meeting of its shareholders to approve the merger transaction as soon as possible.
Furthermore, in order to obtain all the aforementioned approvals, the Company and NLS agreed to extend the final date for completion of the merger transaction by 90 days, i.e. until April 30, 2025. On February 28, NLS, together with the Company, announced that they submitted an amended F4/A1 statement to the SEC regarding the proposed merger. 2.As of the date of approval of these financial statements, the merger transaction with NLS has received the approvals of the District Court in Lod, the TASE, and the Israel Securities Authority. B. Kadimastem and NLS report on a private fundraising of up to USD $3 million for NLS and the signing of a framework agreement for an investment of USD $25 million in NLS. On March 31, 2025, the Company, along with NLS, announced an additional private fundraising round for NLS in the amount of USD $3 million at a share price of USD $1.65, reflecting a premium of 10% over the NLS share price (hereinafter, “the fundraising”), with USD $2 million of the total fundraising completed as of the date of [these financial statements], and the remaining amount of up to USD $1 million, subject to the registration of the Shares and the approval of the NLS shareholders’ meeting, as part of the actions being taken towards completion. At the same time, a framework agreement for an investment of USD $25 million in NLS was also signed. Annex G-44 KADIMASTEM LTD.
NOTES TO FINANCIAL STATEMENTS Note 23: — SUBESEQUENT Events (cont.) The purpose of the aforementioned fundraising efforts is to secure financing for the merger transaction and for post -mergerworking capital, as well